Research Article
Design, Characterization, and Optimization of Controlled Drug Delivery System Containing Antibiotic Drug/s
Table 6
Formulation of osmotic tablet (F21–F27).
| | Ingredient | Batch number | | F21 | F22 | F23 | F24 | F25 | F26 | F27 |
| | Dicloxacillin sodium (mg) | 244 | 244 | 244 | 244 | 244 | 244 | 244 | | NaCl (mg) | 100 | 150 | 150 | 50 | 150 | 100 | 100 | | SLS (mg) | 20 | 15 | 10 | 10 | 15 | 15 | 15 | | PVP K30 (mg) | 15 | 15 | 15 | 15 | 15 | 15 | 15 | | CA (%) | 2 | 2 | 3 | 3 | 4 | 3 | 3 | | PEG 400 (%) | 2 | 2 | 2 | 2 | 2 | 2 | 2 | | Magnesium stearate (mg) | 3 | 3 | 3 | 3 | 3 | 3 | 3 | | Talc (mg) | 3 | 3 | 3 | 3 | 3 | 3 | 3 | | Coloring agent | q.s | q.s | q.s | q.s | q.s | q.s | q.s |
|
|
